Smad7 was recently shown to antagonize TGF-b-induced activation of signal-transducing Smad2 and Smad3 proteins. However, the biological function of Smad7 in the process of lung organogenesis is not known. Since Smad2/3-mediated TGF-b signaling is known to inhibit embryonic lung branching morphogenesis, we tested the hypothesis that Smad7 regulates early lung development by modulating TGF-b signal transduction. An antisense oligodeoxynucleotide (ODN) was designed to speci®cally block endogenous Smad7 gene expression at both transcriptional and translational levels in embryonic mouse lungs in culture. TGF-b-mediated inhibition of lung branching morphogenesis was signi®cantly potentiated in cultured embryonic lungs in the absence of Smad7 gene expression: abrogation of Smad7 potentiated TGF-b-mediated inhibition of lung branching morphogenesis from 76 to 52% of the basal level in lungs cultured in the presence of 5 ng/ml TGF-b1 ligand. Likewise, TGF-b1 EC 50 (concentration of TGF-b1 that induced half maximal branching inhibition) was reduced from 5 to 1 ng/ml when Smad7 gene expression was abrogated in lung culture, indicating an enhanced level of TGF-b signaling in lung tissue with abolished Smad7 gene expression. By immunocytochemistry, Smad7 protein was co-localized with both Smad2 and Smad3 in distal bronchial epithelial cells, supporting the concept that Smad7 inhibits TGF-b signaling by competing locally with Smad2 and Smad3 for TGF-b receptor complex binding during lung morphogenesis. Furthermore, antisense Smad7 ODN increased the negative effect of TGF-b1 on epithelial cell growth in developing lungs in culture. We also demonstrated that Smad7 mRNA levels were rapidly and potently induced upon TGF-b1 stimulation of lungs in culture, suggesting that Smad7 regulates TGF-b responses in a negative feedback loop. These studies de®ne a novel function for Smad7 as an intracellular antagonist of TGF-b-induced, Smad2/3-mediated inhibition of murine embryonic lung growth and branching morphogenesis in culture. The optimization of TGF-b signaling during early lung development therefore requires a ®nely-regulated competitive balance between both permissive and inhibitory members of the Smad family. q
Introduction
Members of the transforming growth factor-b (TGF-b) family, such as TGF-bs, bone morphogenetic proteins (BMPs), activins, and Dpp, are multifunctional autocrine/ paracrine signaling molecules that play important roles in embryonic pattern formation and affect many parameters of cell behavior including cell proliferation, migration, transdifferentiation, survival, and apoptosis (recently reviewed by . TGF-b signaling occurs via ligandinitiated heteromeric complex formation of distinct type I and type II serine/threonine kinase receptors (Derynck and Feng, 1997; Massague Â et al., 1997) . Upon phosphorylation and activation of TGF-b type I receptor by the constitutively active type II receptor kinase, the signal is propagated downstream through the activation of Smad proteins. TGF-b pathway-restricted Smad2 and Smad3 transiently interact with and become phosphorylated by the activated TGF-b type I receptor on their C-terminal Ser-Ser-X-Ser consensus sites, after which they oligomerize with the common mediator Smad4 . The hetero-oligomeric Smad complex is then translocated to the nucleus and regulates the transcription of target genes in association with coactivators such as FAST-1 and p300/ CBP (Chen et al., 1997; Feng et al., 1998; Janknecht et al., 1998; Pouponnot et al., 1998) . Therefore, Smad proteins play a pivotal role in relaying TGF-b signaling from cell surface receptors to the nucleus.
Recently, a distinct subclass of distantly related Smads, including Drosophila Dad, Xenopus XSmad6 and XSmad7, and mammalian Smad6 and Smad7, have been identi®ed as intracellular antagonists of TGF-b family signaling (Hayashi et al., 1997; Imamura et al., 1997; Nakao et al., 1997; Tsuneizumi et al., 1997; Nakayama et al., 1998) . Both Smad6 and Smad7 diverge structurally from other members of the Smad family by the lack of the C-terminal phosphorylation motif (Whitman, 1997) . Smad6 and Smad7 interact stably with the activated TGF-b type I receptor, thereby interfering with the association, phosphorylation, and activation of cognate pathway-restricted Smads. Consequently, active heteromeric Smad complexes are not formed. As inhibitory Smads show a more stable interaction with type I receptors than do pathway-restricted Smads, Smad6 and Smad7 could`switch off' TGF-b signals through competitive inhibition of the Smad binding site on the TGF-b type I receptor kinase. Furthermore, transcription of inhibitory Smad mRNA is potently induced by TGF-b stimuli (Nakao et al., 1997) , suggesting that inhibitory Smads act in an auto-regulatory feedback loop to attenuate the signal transduction of the TGF-b superfamily.
TGF-b signaling is implicated in the negative regulation of lung growth and development during early lung organogenesis (recently reviewed by Warburton et al., 1999 Warburton et al., , 2000 . We have previously demonstrated that TGF-b pathwaypermissive Smad2 and Smad3 are required for the transduction of TGF-b-mediated inhibition on both embryonic lung branching morphogenesis and epithelial cell differentiation (Zhao et al., 1998a) . Although ®nely-regulated Smadmediated TGF-b signaling is responsible for normal lung development, the biological signi®cance of inhibitory Smad proteins during lung branching morphogenesis remained enigmatic.
In the present study, the functional role of inhibitory Smad7 was de®ned using embryonic lungs in ex vivo culture that undergo extensive branching morphogenesis and cytodifferentiation. We found that Smad7 transcription was rapidly induced upon TGF-b1 stimulation in cultured lungs, suggesting that Smad7 participates in a negative feedback loop to modulate TGF-b responses. While Smad7 functions as an antagonist of TGF-b signaling, we postulate that Smad7 gene expression instructs lung branching morphogenesis through regulating the magnitude of TGFb signaling. To test the above hypothesis, an antisense oligodeoxynucleotide (ODN) was devised to abrogate endogenous Smad7 gene expression, in a loss-of-function approach, during embryonic lung morphogenesis in culture. We found that Smad2/3-mediated, TGF-b-induced inhibition of both lung branching morphogenesis and pulmonary epithelial cell growth were signi®cantly potentiated when endogenous Smad7 gene expression was abrogated. Therefore, the augmented TGF-b signaling in the absence of Smad7 indicates that`anti-Smads' such as Smad7 are indispensable for the optimization of TGF-b signaling during early lung growth and development.
Results
2.1. TGF-b 1 induces Smad7 mRNA expression in embryonic lungs in culture E11.5 embryonic mouse lungs were cultured with the addition of TGF-b1 ligand for up to 4 days. Competitive RT-PCR quanti®cation of Smad7 revealed that Smad7 mRNA was induced by TGF-b1 in lung culture (Fig. 1) . The expression of Smad7 mRNA was most prominently induced after only 1 day of addition of exogenous TGF- Fig. 1 . Competitive RT-PCR for Smad7 mRNA quanti®cation. (a) A same pair of primers (primers 1 and 2, black boxes) were adopted to amplify both Smad7 cDNA and Smad7 competitor, and the corresponding PCR products were 321 and 430 bp in length, respectively. (b) A ®xed amount of Smad7 competitor (1 fg) was used to co-amplify with a 1:2 serial dilution of Smad7 cDNA (lanes 1±10, 0.0625±16 fg), and the resultant electrophoretic pattern displayed a reverse correlation of intensities between Smad7 cDNA and its competitor bands. (c) A linear relationship (closed circles) was derived from an electrophoretic pattern with high coef®cient factor (R 2 . 0:95) following densitometric scanning of both Smad7 and its competitor band intensities, while a similar line with identical slope value was acquired when different amounts of reserve-transcribed total RNA was used (open circles). b1 (5 ng/ml) in lungs in culture, and decreased time-dependently thereafter. Smad7 mRNA expression peaked at a 15.8-fold (P , 0:05) induction at 1 day and was reduced to a lower level of TGF-b1 stimulation (4.8-fold, P , 0:05) at 4 days, indicating that Smad7 is a TGF-b1-responsive gene during embryonic lung branching morphogenesis. Smad7 mRNA levels were not signi®cantly up-regulated in lung culture in the absence of TGF-b1. Additionally, TGF-b1 did not induce Smad3, a TGF-b pathway-speci®c Smad, mRNA expression in embryonic lungs in culture, as assessed by Smad3 competitive RT-PCR measurement. The temporal pattern of inhibitory Smad7 mRNA expression demonstrates that the Smad7 gene is both rapidly and consistently induced in response to TGF-b1 treatment during early lung growth and morphogenesis.
Inhibition of endogenous Smad7 gene expression using Smad7 antisense oligodeoxynucleotide in lung culture
To investigate the functional role of endogenous Smad7 during embryonic mouse lung development, a Smad7 antisense oligodeoxynucleotide (ODN) inhibition strategy was utilized in lung culture in a loss-of-function fashion. In the current study, an antisense ODN to Smad7 was added exogenously to embryonic mouse lung explants in culture, while lungs in scrambled ODN, sense ODN, or plain media were included as controls for both speci®city and toxicity of ODN. Inhibition of endogenous Smad7 gene expression using antisense ODN to Smad7 in lung culture was veri®ed by quanti®cation of mouse Smad7 mRNA levels in culture lung. Competitive RT-PCR assays were developed, as described in Section 4, to measure the endogenous amounts of Smad7 mRNA in lungs cultured with Smad7 antisense ODN or its corresponding control ODNs. As illustrated in competitive PCR electrophoretic patterns in Fig. 2a , embryonic lungs cultured in 50 mM doses of both scrambled and sense (data not shown) control ODNs to Smad7 yielded amounts of Smad7 mRNA comparable to media control, whereas lungs treated with antisense ODN to Smad7 (50 mM) demonstrated a reduced level of endogenous Smad7 mRNA. Therefore, only Smad7 antisense ODN, not scrambled or sense control ODN, ef®ciently inhibited endogenous Smad7 gene expression in lungs in culture. TGF-b1 (5 ng/ml) stimulated endogenous Smad7 mRNA expression in lung culture in the presence of either media or scrambled Smad7 ODN control, con®rming the responsiveness of Smad7 gene expression to TGF-b stimuli. In contrast, not only did TGF-b1 fail to induce Smad7 mRNA transcription but also the basal level of Smad7 mRNA was inhibited in embryonic lungs treated with both Smad7 antisense ODN and TGF-b1. Due to the linearity of the Smad7 competitive PCR standard curve (Fig. 3) , amounts of Smad7 mRNA under different conditions were visually compared based on the electrophoretic patterns (Fig. 2a) ; however, accurate measurements were also derived following densitometric analysis (Fig. 2b) . Antisense ODN to Smad7 signi®cantly inhibited endogenous Smad7 mRNA levels in cultured lungs regardless of the presence of TGF-b stimulation: endogenous Smad7 mRNA amounts were reduced to a remnant 2.8 and 9.9% (P , 0:05) of the basal level in the absence and presence of TGF-b1, respectively. In comparison, TGF-b1 increased Smad7 mRNA expression in control (media, scrambled, and sense) ODN-treated lung cultures.
Smad7 is known to antagonize TGF-b signaling by competing with TGF-b pathway-permissive Smads (Smad2 and Smad3) for binding of the TGF-b type I receptor. To ensure that antisense ODN to Smad7 speci®cally inhibits mouse Smad7 mRNA expression, but not other Smad gene expression, Smad3 mRNA levels were measured in the lung culture treated with Smad7 ODNs. Although antisense ODN to Smad7 ef®ciently attenuated Smad7 mRNA expression in embryonic murine in culture, endogenous Smad3 mRNA levels were not adversely affected by antisense ODN to Smad7, as demonstrated in Smad3 competitive PCR assays (Fig. 2a) . Smad6, another inhibitory Smad protein, gene expression was also found not to be changed with Smad7 antisense ODN treatment in embryonic lung in culture (Fig. 2a) . Therefore, Smad7 antisense ODN inhibited endogenous Smad7 gene expression both ef®ciently and speci®cally during lung morphogenesis in culture. Total proteins were extracted from cultured embryonic lungs for Western analysis. Cultured lungs treated with 50 mM antisense Smad7 ODN, with or without the addition of exogenous TGF-b1, resulted in reduced levels of Smad7 protein (Fig. 4) . In comparison, lungs with scrambled ODN or media control treatment did not show altered levels of endogenous Smad7 protein expression. Such an inhibition of Smad7 protein levels using Smad7 antisense ODN in lung culture seemed to be speci®c, since endogenous Smad3 protein amounts stayed relatively constant regardless of Smad7 ODN treatment. Therefore, the Smad7 antisense ODN designed herein both signi®cantly and speci®cally inhibits its corresponding Smad7 expression at both transcriptional and translational levels during embryonic mouse lung branching morphogenesis in culture, regardless of the stimulation of TGF-b ligands.
Abrogation of endogenous Smad7 gene expression potentiates TGF-b -mediated negative regulation of embryonic lung branching morphogenesis
Since Smad7 attenuates TGF-b signaling in an auto-regulatory feedback loop, the resultant biological impact of Smad7 gene expression during early lung development was examined in embryonic mouse lung culture using a loss-of-function approach. The Smad7 antisense ODN we devised above was used to achieve effective inhibition of Smad7 gene expression during lung morphogenesis in culture. TGF-b1, when added at a dose of 1 ng/ml, did not signi®cantly inhibit epithelial branching morphogenesis in culture in both media control and Smad7 scrambled ODN-treated lungs (96.6 and 93.7% of the basal level, respectively), whereas the same dose of TGF-b1 showed a signi®cant lung branching inhibition (72.7% of the basal level, P , 0:05) in lungs cultured with Smad7 antisense ODN (Fig. 5A ). Thus, TGF-b1 at the dose of 1 ng/ml demonstrated an observable inhibition of peripheral lung branching in culture only when endogenous Smad7 gene expression was abrogated using Smad7 antisense ODN, . Smad7 antisense ODN also decreases Smad7 protein levels in embryonic mouse lungs in culture. Embryonic mouse lungs were cultured with plain media, scrambled or antisense ODN to Smad7, either in the absence or in the presence of TGF-b1 ligand. Harvested lungs were used for Western analysis. In comparison with either media control (MC) or scrambled (SR) ODN control, reduced levels of Smad7 protein amounts were detected in cultured lungs treated with Smad7 antisense ODN, regardless of the addition of exogenous TGF-b1. However, protein levels of TGFb pathway-speci®c Smad3 were apparently inert to the administration of Smad7 antisense ODN, whether in the presence or in the absence of exogenous TGF-b1. b-Actin was used to ensure equal loading for Western analysis.
while the same dose of exogenous TGF-b1 did not show a signi®cant inhibitory effect on lung morphogenesis in either plain media or scrambled Smad7 control ODN-treated lung culture.
Higher concentrations of TGF-b1 (5 ng/ml, or 0.2 nM) signi®cantly inhibited terminal branching in lungs cultured with either plain media or scrambled control ODN to Smad7: 76.1 and 73.7% (P , 0:05) of the basal level, respectively. However, pulmonary branching was further reduced to 52.2% (P , 0:05) in comparison to the basal level by 5 ng/ml TGF-b1 in the presence of Smad7 antisense, indicating that the TGF-b1-mediated negative effect on lung morphogenesis was potentiated when endogenous Smad7 gene expression was abrogated during lung growth. Thus, the negative effect of TGF-b signaling on lung branching was augmented during lung development in the absence of Smad7 gene expression.
The concentration-dependent effects of TGF-b1 on lung culture in the presence of either media control, Smad7 scrambled control, or Smad7 antisense ODN are compared in Fig. 5B . The resultant patterns of lung branching morphogenesis in response to various doses of exogenous TGF-b1 were therefore determined (Fig. 5B) . While TGF-b1 inhibited lung branching morphogenesis in a concentrationdependent fashion in cultured lungs regardless of treatment of media control, Smad7 scrambled, or Smad7 antisense ODN, a signi®cant intensi®cation of TGF-b-induced negative regulation on lung branching was observed in lungs without Smad7 gene expression at each speci®c TGF-b dose assayed. The EC 50 (TGF-b1 concentration of half maximal inhibition) dose of TGF-b1 on lung branching inhibition was reduced 5-fold from 5 ng/ml in normal embryonic lungs in culture to 1 ng/ml in cultured lungs with abrogated Smad7 gene expression. Furthermore, the maximal level of TGF-b1-mediated inhibition of lung terminal branching morphogenesis was reduced from 57 to 41% of the basal level in Smad7 gene abrogated lungs. Taken together, abrogation of Smad7 gene expression resulted in elevated TGF-b signaling and a concomitant potentiation of TGF-b-mediated inhibition of embryonic lung branching morphogenesis.
Smad7 and Smad2/3 co-localize to distal epithelium in embryonic mouse lungs
To further test our hypothesis that Smad7 participates in the TGF-b-mediated negative regulation of lung growth through interfering with TGF-b pathway-restricted Smads, an immunocytochemical study was performed for both TGFb permissive and inhibitory Smads in cultured lungs (Fig.  6A ). Smad7 protein immunostaining was found in distal epithelial cells with high intensity (Fig. 6A, a1 and a2), consistent with Smad7 protein participating in regulating distal lung epithelial branching morphogenesis. However, Smad7 immunoreactivity was low in proximal airway epithelial cells, and pulmonary mesenchymal cells were . Although addition of a relatively low concentration of TGF-b1 (1 ng/ml) did not show a signi®cant lung branching inhibition in the presence of Smad7 scrambled control ODN (c), a signi®cant inhibition on lung morphogenesis was observed at the same dose of TGF-b1 when Smad7 antisense ODN replaced Smad7 scrambled control ODN (d). While a higher dose of TGF-b1 (5 ng/ml) inhibited lung branching in media containing Smad7 scrambled control ODN (e), the same dose of TGF-b1 further reduced lung morphogenesis in culture when Smad7 antisense ODN was used instead (f). Bar, 100 mm. (B) Addition of TGF-b1 to lung culture negative modulated pulmonary branching morphogenesis in a concentration-dependent fashion, either in the presence of media control or Smad7 scrambled (SR) ODN control. Such a dose-dependent TGF-b1-induced lung branching inhibition was potentiated when endogenous Smad7 gene expression was attenuated using Smad7 antisense (AS) ODN in embryonic lungs in culture. Error bars represent standard deviation. free of Smad7 protein. On serial lung sections (Fig. 6A, b1 and b2), Smad7 and Smad2/3 were shown to have overlapping patterns of localization in terminal lung epithelium (Fig.  6A, b1 shows Smad7 and b2 shows Smad2/3; an antibody that recognizes both Smad2 and Smad3 was used in b2), suggesting that Smad7, like Smad2 and Smad3, is involved in regulation of lung growth and differentiation through endoderm±mesoderm interaction. Smad6 protein localization was distinguished from that of Smad7 in developing lung by its primary distribution in lung mesenchymal cells with relatively low immuno-intensity (Fig. 6A, c) , while lung sections incubated with normal goat IgG yielded negligible background staining (Fig. 6A, d) . Therefore, our observation that Smad7 and Smad2/3 proteins co-localize in terminal airway epithelial cells suggests that Smad7 may regulate lung epithelial±mesenchymal interaction during early lung morphogenesis, possibly through competitive inhibition of Smad2/3 binding onto the TGF-b type I receptor kinase. Smad7 mRNA was also localized in mouse lungs at both E11 and E12 stages, using whole-mount in situ hybridization (Fig. 6B ). In correlation with Smad7 immunohistochemistry in cultured embryonic lungs, Smad7 mRNA transcripts were visualized primarily in terminal epithelium (Fig. 6B, a and b) , further supporting the notion that Smad7 is directly implicated in distal lung branching morphogenesis through regulation of TGF-b signaling magnitude during early lung organogenesis. However, Smad7 mRNA was also found, to a lesser extent, in adjacent pulmonary mesenchyme (Fig. 6B, a and b) .
Abrogation of Smad7 potentiates TGF-b1-mediated inhibition of epithelial cell proliferation in cultured embryonic lungs
Finally, the biological importance of Smad7 protein during early lung development was studied for its impact on pulmonary epithelial cell proliferation during lung development in culture. TGF-b-induced growth arrest occurs late in the G1 phase and is accompanied by a reduction in the cell proliferation rate in mammalian cells. Proliferating cell nuclear antigen (PCNA), an auxiliary nuclear co-factor mediating DNA polymerase during replication of DNA, was used as a marker for cell proliferation. As shown in Fig. 7 , PCNA proliferative indices in lung epithelium, which represent the proliferation rate in pulmonary epithelial cells during embryonic lung morphogenesis, were carried out on cultured lung sections. In embryonic lungs treated with a low dose of TGF-b1 (1 ng/ml) in the presence of Smad7 scrambled control ODN, the PCNA index (percentage of PCNA-positive cells in airway epithelium) was not signi®cantly altered (40.6), in comparison with 47.1 in controls without exogenous TGF-b1. On the other hand, the PCNA index in epithelial cells was signi®cantly reduced to 31.5 (P , 0:05) in Smad7 antisense ODN-treated lung cultures treated with 1 ng/ml TGF-b1. Thus, attenuation of endogenous Smad7 gene expression greatly sensitizes TGFb-mediated inhibition of epithelial cell proliferation during early lung branching morphogenesis in culture, indicating that the normal expression of Smad7 gene counter-acts TGF-b-induced cell cycle arrest in airway epithelium.
Higher concentrations of TGF-b1 (5 ng/ml) showed a decreased PCNA index (30.4) in cultured embryonic mouse lungs treated with scrambled control Smad7 ODN. However, the same dose of TGF-b1 further reduced the PCNA index to 20.2 in Smad7 antisense ODN-treated lungs in culture, supporting the anti-cell cycle arrest role of Smad7 during TGF-b-mediated lung epithelial branching inhibition. Therefore, Smad7 antagonizes TGF-b-induced inhibition of lung morphogenesis by attenuating the TGFb-mediated growth arrest of lung epithelial cells.
Discussion
The recent identi®cation of the Smad family of signal transducing proteins has unraveled the novel molecular mechanism by which TGF-b signals from the cell membrane to the nucleus. Pathway-speci®c Smads are phosphorylated by cognate cell-surface receptors that have serine/threonine kinase activity, then oligomerize with the common mediator Smad4 and translocate to the nucleus where they direct transcription to affect the cellular response to TGF-b. On the other hand, inhibitory Smads have been identi®ed that antagonize, rather than transduce, the activation of pathway-restricted Smads. Thus, Smad proteins are identi®ed as intracellular mediators for both positive and negative modulation of TGF-b signaling.
De®ning the speci®cities of inhibitory Smads with respect to upstream ligands, receptors, and downstream signaling Smads is critical for understanding their biological functions during lung growth. Overexpression of Smad7 inhibits phosphorylation of both Smad2 and Smad3 by activated TGF-b type I receptor (Hayashi et al., 1997; Nakao et al., 1997) . In mink lung epithelial cells, Smad7, but not Smad6, inhibits TGF-b1-induced growth inhibition and the expression of immediate early response genes including Smad7 itself, while Smad7 accumulates in the cytoplasm upon TGF-b receptor activation (Itoh et al., 1998) . Smad7 could, therefore, be a generalized inhibitor of signaling by the TGF-b pathway. Smad6 has been shown to bind to and inhibit signaling downstream of BMP receptors and to prevent formation of an active Smad4/Smad1 signaling complex by directly competing with Smad4 for binding to Smad1 (Imamura et al., 1997; Hata et al., 1998) . To elucidate the functional importance of inhibitory Smads in lung growth and development, we chose herein to focus on the molecular role of inhibitory Smad7 in antagonizing the transduction of TGF-b signals during embryonic mouse lung branching morphogenesis in culture.
We found that Smad7 transcription is both potently and rapidly induced by the addition of exogenous TGF-b1 in cultured embryonic lungs. An antisense ODN approach was subsequently used to successfully block the Smad7 gene expression on both transcriptional and translational levels during early lung development in culture. Attenuation of Smad7 gene expression signi®cantly potentiated TGF-b1-mediated inhibition of lung branching morphogenesis, indicating that TGF-b signaling is intensi®ed in the absence of endogenous Smad7. Additionally, an increased susceptibility to TGF-b-induced down-regulation of epithelial cell proliferation was observed in lungs without Smad7 gene expression, further supporting the notion that Smad7 is necessary for the negative regulation of TGF-b signaling during lung development. Our study now de®nes a novel functional mechanism by which inhibitory Smad7 participates in lung branching and growth through suppressing TGF-b signal transduction. Therefore, signaling in the TGF-b pathway during normal lung morphogenesis re¯ects a delicate competitive balance between both positive and negative members of the Smad family.
Smad7 antisense ODN was strategically designed to abrogate endogenous Smad7 gene expression during lung branching in culture, enabling us to investigate the functional signi®cance of Smad7 during early lung organogenesis in a loss-of-function manner. Non-homologous Smad7 antisense ODN sequence was carefully chosen¯anking the translation initiation codon, the sequence known empirically to be most effective in inhibiting translation of target mRNA (Marcus-Sekura, 1988) . We have shown previously that short ODNs diffuse into mammalian cells, hybridize to nascent mRNA transcripts, and effectively inhibit transcription/translation without noticeable cytotoxicity (Warburton et al., 1992; Chai et al., 1994; Zhao et al., 1996) . In the current study, the effectiveness of Smad7 antisense ODN was validated by both competitive RT-PCR assay and Western blot, ensuring that both Smad7 mRNA and protein levels were signi®cantly down-regulated using antisense ODN to Smad7 in embryonic lung in culture. Furthermore, the Smad7 antisense ODN we used in lung culture speci®-cally attenuates endogenous Smad7 gene expression, since gene expression of other members in the Smad family, including Smad2, 3, and 6, was not adversely affected in cultured lungs, as demonstrated by competitive RT-PCR quanti®cation and Western blot analysis. Ectopic expression of antisense Smad7 mRNA has also been used in lung cancer cell lines to increase the effect of TGF-b1, supporting the role of Smad7 as a negative regulator in TGF-b signaling (Afrakhte et al., 1998) . Taken together, the observed effect of elevated TGF-b signaling on both lung branching morphogenesis and pulmonary gene expression in the current study is attributed solely to the loss of endogenous Smad7 protein in embryonic lungs in culture, and not to any other proteins in the Smad family.
The Drosophila inhibitory Smad homologue Dad is induced by the TGF-b homologue Dpp (Tsuneizumi et al., 1997) . Transcription of inhibitory Smad7 mRNA is induced by stimulation of TGF-b in a number of cell lines including mink lung epithelial cells (Nakao et al., 1997; Afrakhte et al., 1998; Ishisaki et al., 1998) . In embryonic mouse lungs in culture, the Smad7 mRNA level was vigorously induced by exogenous TGF-b1 stimulation. Elevated Smad7 gene expression in response to TGF-b ligand suggests that inhibitory Smad7 functions in a negative feedback loop to suppress Smad2/3-mediated TGF-b signaling during lung morphogenesis. The magnitude of Smad-mediated TGF-b pathway signaling is thereby auto-regulated in a negative feedback loop during early lung development.
To con®rm our results that Smad7 antagonizes TGF-b pathway-permissive Smad2/3-mediated TGF-b signal transduction in lung development, we investigated the localization pattern of inhibitory Smad7. Smad7 proteins were found exclusively in terminal airway epithelium, suggesting that Smad7 participates in distal lung epithelial branching regulation through epithelial±mesenchymal interaction. Consistent with Smad7 protein immunolocalization, Smad7 mRNA transcripts were mainly detected in epithelium lining the distal branching airway. Additionally, Smad2/3 and Smad7 proteins were co-localized to distal bronchial epithelial cells, providing evidence that both Smad2/3 and Smad7 compete for binding to TGF-b type I receptor during lung morphogenesis in culture. Our observation that Smad7 protein shares an overlapping localization pattern with both Smad2 and Smad3 protein in distal epithelium further supports the concept that TGF-bmediated mesoderm±endoderm interaction during lung morphogenesis is modulated by both permissive and inhibitory Smad gene expression.
Although Smad7 is the focus of our current studies to elaborate the mechanism of TGF-b signaling during lung growth and differentiation, other candidate intracellular modulators of the TGF-b pathway have also been identi®ed. Two TGF-b type I receptor binding proteins, STRAP (serine-threonine kinase receptor-associated protein) and TRIP-1 (TGF-b receptor interacting protein-1), are noted to repress TGF-b responses in Mv1Lu cells (Choy and Derynck, 1998; Datta et al., 1998) . In particular, overexpression of STRAP shows a synergistic inhibition of TGFb signaling in concert with Smad7 (Datta et al., 1998) . Like Smad7, STRAP and TRIP-1 may have regulatory roles in TGF-b signaling. While our ®nding that abrogation of Smad7 intensi®es TGF-b-mediated inhibition on both lung growth and differentiation suggests that Smad7 negatively modulates Smad2/3-mediated positive TGF-b signaling during early lung development, other intracellular modulatory proteins such as STRAP and TRIP-1 may also play a role in attenuating TGF-b signal transduction during the process of lung morphogenesis.
Aberrant expression of TGF-b signaling, occurring as a result of lung disease and injury, could perturb ®nely regulated TGF-b-mediated molecular cascades, resulting in abnormalities of lung growth, differentiation, and development. Excessive TGF-b signaling is known to play an important role in chronic ®brotic lung injury in humans and rats as well as in bleomycin-induced lung ®brosis in animals (Khalil et al., 1993; Sime et al., 1997) . Smad7, but not Smad6, was recently used to ameliorate bleomycin-induced lung ®brosis in mice (Nakao et al., 1999) . Smad7 recombinant adenovirus was introduced into ®brotic mouse lungs via intra-tracheal injection. Those mice carrying the Smad7 adenoviral transgene demonstrated suppression of type I pre-collagen mRNA, reduced hydroxyproline content, and no morphological ®brotic responses to bleomycin. The latter study suggested that Smad7 could possibly be adapted to the treatment of lung injuries and diseases due to abnormal TGF-b signaling.
Functionally inactive mutations have also been discovered in both permissive and inhibitory Smads in cancers of pancreas, colorectum, breast, and lung (Eppert et al., 1996; Hahn et al., 1996; Riggins et al., 1996; Schutte et al., 1996; Kleeff et al., 1999) . Smad3 mutant mice were noted to develop metastatic colorectal cancer between 4 and 6 months of age (Zhu et al., 1998) . Abnormal TGF-b signaling could therefore adversely disrupt the orderly temporospatial molecular cascades that normally govern lung morphogenesis and cytodifferentiation as seen in pathological lung tissue. Therefore, ®nely regulated TGF-b signaling appears to be essential for the normal lung growth and development. Smad2, Smad4, and Smad7 are organized in a single gene cluster on the 18q21 region by chromosomal mapping (Jonson et al., 1999) , indicating that both permissive and inhibitory Smad gene expression may be coordinately regulated during tissue development. Like permissive Smad2/3, inhibitory Smad7 constitutes an important regulatory step to modulate TGF-b signaling during embryogenesis and tissue development.
We conclude that Smad7 plays an important functional role in modulating TGF-b signaling during lung growth and development through antagonizing Smad2/3-mediated TGF-b signaling. Smad7 attenuates TGF-b-mediated lung branching inhibition and epithelial cell growth arrest during early development of lung tissue. Therefore, Smad7 is likely to be responsible at least in part for normal regulation of TGF-b signaling during lung organogenesis. Thus, optimal TGF-b signaling requires a ®nely-modulated, dynamic, and competitive balance between positive and negative signal transduction by members of the Smad gene family.
Materials and methods

Smad7 antisense oligodeoxynucleotide (ODN)
A 16 bp Smad7 antisense oligodeoxynucleotide (ODN), 5 H -GTT TGG TCC TGA ACA T-3 H , was designed to employ non-homologous sequences that surround the AUG initiation codon of Smad7 mRNA (Nakao et al., 1997) . In addition, two same-length negative control ODNs were chosen to verify the sequence speci®city of the Smad7 antisense ODN: (i) a randomly scrambled ODN with the same nucleotide composition to antisense sequence; and (ii) the corresponding sense ODN. Smad7 antisense and their control ODNs were synthesized with phosphorothioate modi®ca-tion (USC MicroChemical Core Facility, Los Angeles, CA). Puri®ed ODNs were dissolved in sterile water and quantitated by optical density at OD 260 .
Mice, lung tissue preparation, and organ explant culture
Timed pregnant Swiss±Webster female mice were obtained from Simonsen Laboratories by mating and checking for vaginal plugs on the same day so that the variation in gestational age was less than 6 h. Embryos from embryonic day 11.5 (E11.5, day of plug is de®ned as E0) were dissected in sterile Hank's balanced salt solution (GIBCO BRL), and the lungs were removed by microdissection.
Early mouse embryonic lung primordia (E11.5) were cultured under serum-free, chemically-de®ned conditions as reported previously (Jaskoll et al., 1988) . TGF-b ligands (R&D Systems, Minneapolis, MN) and/or Smad7 ODNs were added to the culture media to desirable concentrations. Cultured lungs were processed for quanti®cation of terminal branches, RNA extraction, and/or immunocytochemistry.
Quanti®cation of lung branching morphogenesis
Because branching morphogenesis per se is the key bioassay read-out for determining the functional role of Smad7 during early lung organogenesis, three independent measurements of branching morphogenesis were used: (i) the number of airway generations from the trachea to the most distal branch of the longest visible airway; (ii) the number of air sacs visible around the periphery of the lung explants; and (iii) computerized pattern recognition analysis of the number of individual terminal respiratory units in the whole explant. These analyses were performed on whole-mounts of lung explants without knowledge of the assay conditions, using transillumination to visualize structures and photomicroscopy to record permanent images. Paraf®n-embedded sections of cultured lung tissue after ®xation were also examined to verify the counting of terminal branching.
RNA extraction, reverse transcription, and competitive PCR assays
Total RNA from cultured lung explants was extracted by guanidinium thiocyanate following homogenization as we have documented elsewhere (Zhao et al., 1996) . Extracted total RNA was immediately reverse-transcribed by incubating at 378C for 1 h in the presence of ribonuclease inhibitor, oligo-d(T) 12±18 , and M-MLV reverse transcriptase (GIBCO BRL). The resultant cDNA products were used for competitive PCR quanti®cation.
Competitive PCR methodology for speci®c mRNA quanti®cation of pulmonary genes has been described previously (Zhao et al., 1996) . For Smad7, a set of primers (primers 1 and 2, Fig. 3a) were designed for mouse Smad7 to amplify a 321 bp cDNA fragment (Nakao et al., 1997) . To generate competitor cDNA for Smad7 competitive PCR assay, the above desired primer sequences (primers 1 and 2) were engineered into a heterologous DNA fragment using the same strategy as we documented earlier (Zhao et al., 1996) . Consequently, both Smad7 cDNA and Smad7 competitor utilize the same set of primers in the Smad7 competitive PCR. The Smad7 competitor was 430 bp in length. Both Smad7 and its competitor PCR products were subsequently DNA sequenced to ensure their identities. Competitive PCR assay for Smad6 was developed in a similar manner as that for Smad7.
PCR ampli®cation was carried out using a modi®cation of a previously described assay for TGF-b type II receptor (Zhao et al., 1998b) . Two microliters of a PCR reaction mixture containing a known amount of competitor was added to reverse-transcribed samples derived from 20±50 ng total RNA or to dilutions of standard cDNA templates in a total volume of 50 ml. b-Actin competitive PCR as an internal control was performed in parallel on the same samples. As a negative control for genomic DNA, nonreverse-transcribed total RNA was also included in the competitive PCR assays.
Western blot analysis
Cultured embryonic lungs were lysed in SDS buffer containing protease inhibitors. Equal amounts of total protein (100 mg) extracted from each conditioned sample were prepared for chemiluminescent Western analysis (Boehringer Mannheim, Indianapolis, IN) as reported (Zhao et al., 1996) . Both Smad7 and Smad3 antibodies (rabbit polyclonal IgG) were generously provided by Dr. Carl-Henrik Heldin (Uppsala, Sweden), and were used at recommended dilutions (Ishisaki et al., 1998) . Immunoblotting with b-actin was also performed to con®rm equal loading in all lanes.
Immunohistochemistry
Cultured lungs were ®xed in 4% paraformaldehyde for 3 h at room temperature and immediately embedded into paraf®n. Embryonic lung sections (5 mm thick) on HistoGrip-coated slides (Baxter, Deer®eld, IL) were subsequently prepared for immunohistochemical study. Smad antibodies (goat polyclonal IgG) were used at concentrations according to the manufacturer's suggestions (Santa Cruz Biotech., Santa Cruz, CA). Biotinylated second antibody and streptavidin-peroxidase conjugate were utilized to detect tethered antibody. Subsequent addition of aminoethyl carbazole chromogen (AEC) generated a reddish precipitate surrounding the corresponding Smad antigen (Zymed, South San Francisco, CA). Normal goat serum, bovine serum albumin, and water were run in parallel with Smad antibodies to ensure speci®cities.
Whole-mount in situ hybridization
Freshly-dissected embryonic mouse lung tissues were ®xed in paraformaldehyde and bleached brie¯y in 5% hydrogen peroxide. Rehydrated tissues were proteinase Ktreated, prehybridized for 1 h, and then hybridized overnight with digoxigenin-labeled Smad7 riboprobe at 658C in a hybridization solution containing 50% formamide. A nonhomologous 602 bp Smad7 cDNA was cloned (Invitrogen, San Diego, CA), and both antisense and sense cRNA probes were synthesized using T7 RNA polymerase with digoxigenin-labeled UTP (Boehringer Mannheim). After hybridization, lung tissues were serial-washed, and incubated with anti-digoxigenin alkaline phosphatase conjugate (Rosen and Beddington, 1993) . Lungs were incubated in color-substrate solution with both NBT (nitroblue tetrazolium) and X-phosphate (5-bromo-4-chloro-3-indolyl phosphate). Smad7 mRNA transcripts were visualized as purple signals, and color development was terminated upon optimal staining intensities. Duplicate lung tissue preparations were used for both sense-and antisense-probe hybridization.
PCNA proliferative index
PCNA immunostaining was performed in a similar manner as for Smad proteins, using a polyclonal IgG antibody at a ®nal concentration of 5 mg/ml (Dako Corp., Carpinteria, CA). Sections were subsequently counterstained with hematoxylin and examined by light microscopy at high magni®cation. Surface epithelial cell nuclei in airway cross-sections were examined and classi®ed as PCNA-positive (red nuclei from AEC staining) or PCNAnegative (blue nuclei from hematoxylin staining). At least 1000 cells laying around the entire circumference of airway cross-sections (both proximal and terminal) were counted. The PCNA index (percentage of PCNA-positive nuclei) was thus determined and its mean value represented an average from at least ten individual lung sections in each condition.
Data processing and statistical analysis
All data in the current study were expressed as the meanŜ D, and the signi®cance of differences between means was evaluated by Student's t-test. A value of P , 0:05 was considered signi®cant.
